Skyline Ventures

Our Team
John G. Freund, MD
Eric M. Gordon, PhD
Stephen J. Hoffman, MD PhD
Yasunori Kaneko, MD

Stephen HoffmanStephen Hoffman

teve joined Skyline in May 2007, based in Boston. Prior to joining Skyline, he was a General Partner of TVM Capital. Steve was the founding President, Chief Executive Officer and a Director of Allos Therapeutics (NASDAQ: ALTH), Inc. where he served as Chairman until 2012. He received his PhD from Northwestern University in chemistry and his MD from the University of Colorado.  Dr. Hoffman completed a fellowship in clinical oncology and a residency and immunodermatology fellowship in dermatology, all at the University of Colorado. Steve is a director of AcelRx Pharmaceuticals, Inc. (ACRX) and is on the board of many of our private companies, which include Collegium Pharmaceutical, Concert Pharmaceuticals, Inc., Dicerna Pharmaceuticals, Genocea Biosciences, Proteon Therapeutics, Inc., and Sutro Biopharma.  Regarding our national pastime, he thinks the designated hitter is an abomination; still, he roots for the Red Sox but his son is a Yankee fan.

HomeAbout UsOur TeamOur PortfolioWhat We Look ForContact Us

2012 Copyright © Skyline Management LLC
web design by San Francisco Web Design & Database